WuXi AppTec is a leading global pharmaceutical and biotechnology company based in China. It was founded in December 2000 and has since grown to become a renowned player in the industry. The company's headquarters are located in Shanghai, China.

Shanghai serves as its primary base for research and development, manufacturing, and commercial operations. The state-of-the-art facilities at the headquarters provide a comprehensive range of services, enabling WuXi AppTec to meet the diverse needs of its clients. WuXi AppTec offers a wide range of products and services to its global clientele.

Its main offerings include platform technology services, small molecule drug discovery and development services, biologics discovery and development services, and medical device services. The company specializes in providing integrated solutions that cover the entire lifecycle of drug discovery and development. With a strong global presence, WuXi AppTec operates across multiple locations worldwide.

It has established notable subsidiaries such as WuXi STA (a contract development and manufacturing organization), WuXi Biologics (a global leader in biologics services), and WuXi Clinical (a provider of clinical research services). Additionally, the company has formed strategic partnerships and joint ventures with various international and domestic organizations to enhance its capabilities and expand its market reach. WuXi AppTec holds a prominent position in the global market, with a strong reputation for its quality services and innovative solutions.

The company has experienced significant growth and success over the years, with its global sales reaching billions of dollars annually. It is considered one of the leading players in the contract research and manufacturing industry, competing with other major multinational companies. The company has achieved various notable milestones and received numerous accolades in recognition of its contributions to the pharmaceutical and biotechnology sectors.

It has consistently focused on enhancing its research and development capabilities, investing in cutting-edge technologies, and expanding its service portfolio to cater to evolving industry demands. As of the latest information available, WuXi AppTec continues to thrive and expand its operations globally. The company remains committed to driving innovation and providing high-quality services to its clients, cementing its position as a key player in the pharmaceutical and biotechnology industry